metricas
Revista Española de Anestesiología y Reanimación (English Edition) Usefulness of severity scales for cardiogenic shock in-hospital mortality. Propo...
Journal Information
Vol. 69. Issue 2.
Pages 65-128 (February 2022)
Cite
Cite
Share
Download PDF
More article options
Visits
1102
Vol. 69. Issue 2.
Pages 65-128 (February 2022)
Original article

Usefulness of severity scales for cardiogenic shock in-hospital mortality. Proposal for a new prognostic model

Utilidad de las escalas de gravedad en la predicción de mortalidad intrahospitalaria en el shock cardiogénico. Propuesta de un nuevo modelo pronóstico
Visits
1102
J.M. Álvarez-Avelloa,b,
Corresponding author
jomaavello@hotmail.com

Corresponding author.
, F.J. Hernández-Pérezc,d, Á. Herrero-Canoa, J.V. López-Iborc, M. Aymerichb, R. Iranzoa, M. Vidal-Fernándeza, M. Gómez-Buenoc,d, B. Gómez-Paratchab, J. García-Suáreza, C.E. Martíne, A. Fortezae, A. González-Romána, J. Segovia-Cuberoc,d
a Servicio de Anestesiología y Reanimación, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain
b Departamento de Anestesiología y Cuidados Intensivos, Clínica Universidad de Navarra, Madrid, Spain
c Servicio de Cardiología, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain
d Centro de Investigación en Red en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain
e Servicio de Cirugía Cardiaca, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Abstract

Cardiogenic shock (CS) is a condition comprising multiple etiologies, which associates high mortality rates. Some scoring systems have been shown to be good predictors of hospital mortality in patients admitted to Critical Care Units (CCU). The main objective of this study is to analyze their usefulness and validity in a cohort of CS patients.

Methods

Observational unicentric study of a cohort of CS patients. SOFA, SAPS II and APACHE II scores were calculated in the first 24 h of CCU admission.

Results

130 patients with CS were included. SOFA, SAPS II and APACHE II scores revealed good discrimination for hospital mortality: (AUC) ROC values (AUC: 0.711, 0.752 and 0.742 respectively; P = .6). Calibration, estimated by the Hosmer-Lemeshow test, was adequate in all cases.

Acute coronary syndrome, lactate serum values, SAPS II score and vasoactive inotropic score (VIS) were found to be independent predictors for mortality, upon ICU admission. With these variables, a specific prognostic indicator was developed (SAPS-2-LIVE), which improved predictive capability for mortality in our series (AUC) ROC, 0.825 (95% CI 0.752−0.89).

Conclusion

In this contemporary CS cohort, the aforementioned scores have been shown to have good predictive ability for hospital mortality. These findings could contribute to a more accurate risk stratification in CS.

Keywords:
Cardiogenic shock
Critical care scoring systems
Vasoactive inotropic score
Temporary mechanical circulatory support
Resumen

El shock cardiogénico (SC) es una entidad que comprende múltiples etiologías y asocia elevada mortalidad. Algunas escalas de gravedad han demostrado ser buenos predictores de mortalidad hospitalaria en pacientes ingresados en Unidades de Cuidados Intensivos (UCI). El objetivo principal de este estudio es analizar su utilidad y validez en una cohorte de pacientes en SC.

Métodos

Estudio observacional unicéntrico. Se calcularon las escalas SOFA, SAPS II y APACHE II en las primeras 24 horas de ingreso en UCI.

Resultados

Se incluyeron 130 pacientes con SC. Las escalas SOFA, SAPS II y APACHE II mostraron buena discriminación para la mortalidad hospitalaria, obteniendo valores de área bajo la curva (AUC) ROC similares (AUC: 0.711, 0.752 y 0.742 respectivamente; P = .6). La calibración, estimada por el test de Hosmer-Lemeshow, fue adecuada en todos los casos, SOFA (P = .787), SAPS II (P = .078) y APACHE II (P = .522).

Resultaron predictores independientes de mortalidad intrahospitalaria: el síndrome coronario agudo (SCA), los valores de lactato sérico, el SAPS II y el índice de vasoactivos inotrópicos (VIS) en las primeras 24 horas de ingreso en UCI.

Con estas variables se desarrolló un indicador pronóstico específico para el SC -SAPS-2-LIVE- que mejora la capacidad predictiva de mortalidad en nuestra serie (AUC) ROC, 0.825 (IC 95% 0.752−0.89).

Conclusión

En esta cohorte contemporánea de SC, las escalas SOFA, SAPS II y APACHE II han demostrado una buena capacidad de predicción de mortalidad hospitalaria. Estos hallazgos podrían contribuir a una mejor estratificación del riesgo en el SC.

Palabras clave:
Shock cardiogénico
Escalas de gravedad
Índice de vasoactivos inotrópicos
Soporte circulatorio mecánico temporal

Article

These are the options to access the full texts of the publication Revista Española de Anestesiología y Reanimación (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
References
[1]
S. Van Diepen, J.N. Katz, N.M. Albert, T.D. Henry, A.K. Jacobs, N.K. Kapur, et al.
Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association.
Circulation., 136 (2017), pp. e232-68
[2]
P.G. Jorens, R. De Paep, P.L. Van Herck, J.L. Van Herck, M.J. Claeys, C.J. Vrints.
Management of cardiogenic shock complicating acute myocardial infarction.
Eur Hear J Acute Cardiovasc Care., 4 (2015), pp. 278-297
[3]
D.A. Baran, F. Co-chair, C.L. Grines, S. Bailey, F.D. Burkhoff, S.A. Hall, et al.
SCAI clinical expert consensus statement on the classification of cardiogenic shock This document was endorsed by the American College of Cardiology (ACC), the American Heart Association ( AHA ), the Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in April 2019.
Catheter Cardiovasc Interv., 1 (2019), pp. 29-37
[4]
J.C. Jentzer, S. van Diepen, G.W. Barsness, T.D. Henry, V. Menon, C.S. Rihal, et al.
Cardiogenic shock classification to predict mortality in the Cardiac Intensive Care Unit.
J Am Coll Cardiol., 74 (2019), pp. 2117-2128
[5]
H. Thiele, U. Zeymer, F.-J. Neumann, M. Ferenc, H.-G. Olbrich, J. Hausleiter, et al.
Intraaortic balloon support for myocardial infarction with cardiogenic shock.
N Engl J Med [Internet]., 367 (2012), pp. 1287-1296
[6]
R.J. Goldberg, F.A. Spencer, J.M. Gore, D.Y.J. Lessard.
Thirty year trends (1975-2005) in the magnitude, management, and hospital death rates associates with cradiogenic shock in patients with acute myocardial infarction: a population-bases perspective.
Circulation., 119 (2009), pp. 1211-1219
[7]
L. Bellumkonda, B. Gul, S.C. Masri.
Evolving concepts in diagnosis and management of cardiogenic shock.
Am J Cardiol., 122 (2018), pp. 1104-1110
[8]
F.J. Hernández-Pérez, J.M. Álvarez-Avello, A. Forteza, M. Gómez-Bueno, A. González, J.V. López-Hibor, et al.
Initial outcomes of a multidisciplinary network for the care of patients with cardiogenic shock.
[9]
J. Arias, J.L. Balibrea.
Utilización de índices de gravedad en la sepsis.
Cirugía Esp., 70 (2013), pp. 314-323
[10]
W.A. Knaus, J.E. Zimmerman, D.P. Wagner, E.A. Draper, D.E. Lawrence.
APACHE-acute physiology and chronic health evaluation: a physiologically based classification system.
Crit Care Med., 9 (1981), pp. 591-597
[11]
W.A. Knaus, E.A. Draper, D.P. Wagner, J.E. Zimmerman.
APACHE II: a severity of disease classification system.
Crit Care Med., 13 (1985), pp. 818-829
[12]
W.A. Knaus, D.P. Wagner, E.A. Draper, J.E. Zimmerman, M. Bergner, P.G. Bastos, et al.
The APACHE III prognostic system: risk prediction of hospital mortality for critically III hospitalized adults.
Chest., 100 (1991), pp. 1619-1636
[13]
J.R. Gall, S. Lemeshow, F. Saulnier.
A new simplified acute physiology score (SAPS II) based on a European/North American Multicenter Study.
JAMA., 270 (1993), pp. 2957-2966
[14]
J.L. Vincent, R. Moreno, J. Takala, S. Willatts, A. De Mendonça, H. Bruining, et al.
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure.
Intensive Care Med., 22 (1996), pp. 707-710
[15]
F.L. Ferreira.
Serial evaluation of the SOFA score to predict outcome in critically ill patients.
JAMA., 286 (2001), pp. 1754-1758
[16]
M. Shankar-Hari, G.S. Phillips, M.L. Levy, C.W. Seymour, V.X. Liu, C.S. Deutschman, et al.
Developing a new definition and assessing new clinical criteria for Septic shock: for the third international consensus definitions for sepsis and septic shock (sepsis-3).
JAMA., 315 (2016), pp. 775-787
[17]
M.E. Kho, E. McDonald, P.W. Stratford, D.J. Cook.
Interrater reliability of APACHE II scores for medical-surgical intensive care patients: a prospective blinded study.
Am J Crit Care., 16 (2007), pp. 378-383
[18]
T.E. Shaughnessy, T.A. Mickler.
Does acute physiologic and chronic health evaluation (APACHE II) scoring predict need for prolonged support after coronary revascularization?.
Anesth Analg., 81 (1995), pp. 24-29
[19]
S.J. Na, C.R. Chung, Y.H. Cho, K. Jeon, G.Y. Suh, J.H. Ahn, et al.
Vasoactive inotropic score as a predictor of mortality in adult patients with cardiogenic shock: medical therapy versus ECMO.
Rev Esp Cardiol., 72 (2019), pp. 40-47
[20]
M.G. Gaies, J.G. Gurney, A.H. Yen, M.L. Napoli, R.J. Gajarski, R.G. Ohye, et al.
Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass.
Pediatr Crit Care Med., 11 (2010), pp. 234-238
[21]
H. Thiele, U. Zeymer, F.-J. Neumann, N. Ferenc, H.-G. Olbrich, J. Hausleiter, et al.
Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, Open-label trial.
Lancet., 382 (2013), pp. 1638-1645
[22]
P. Royston, K.G.M. Moons, D.G. Altman, Y. Vergouwe.
Prognosis and prognostic research: developing a prognostic model.
BMJ., 31 (2009), pp. b604
[23]
M.J. Pencina, R.B. D’Agostino, R.B. D’Agostino, R.S. Vasan.
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.
Stat Med., 27 (2008), pp. 157-172
[24]
V.P. Harjola, J. Lassus, A. Sionis, L. Køber, T. Tarvasmäki, J. Spinar, et al.
Clinical picture and risk prediction of short-term mortality in cardiogenic shock.
Eur J Heart Fail., 17 (2015), pp. 501-509
[25]
D.D. Berg, E.A. Bohula, S. van Diepen, J.N. Katz, C.L. Alviar, V.M. Baird-Zars, et al.
Epidemiology of shock in contemporary cardiac intensive care units.
Circ Cardiovasc Qual Outcomes., 12 (2019),
[26]
P. Kellner, R. Prondzinsky, L. Pallmann, S. Siegmann, S. Unverzagt, H. Lemm, et al.
Predictive value of outcome scores in patients suffering from cardiogenic shock complicating AMI.
Medizinische Klin Und Notfallmedizin., 108 (2013), pp. 666-674
[27]
V. Auffret, Y. Cottin, G. Leurent, M. Gilard, J.-C. Beer, A. Zabalawi, et al.
Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score.
Eur Heart J., 39 (2018), pp. 2090-2102
[28]
M. Schmidt, A. Burrell, L. Roberts, M. Bailey, J. Sheldrake, P.T. Rycus, et al.
Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score.
Eur Heart J., 36 (2015), pp. 2246-2256
[29]
W.C. Chen, K.Y. Huang, C.W. Yao, C.F. Wu, S.J. Liang, C.H. Li, et al.
The modified SAVE score: predicting survival using urgent veno-arterial extracorporeal membrane oxygenation within 24 hours of arrival at the emergency department.
Crit Care., 20 (2016), pp. 1-7
[30]
G. Muller, E. Flecher, G. Lebreton, C.E. Luyt, J.L. Trouillet, N. Bréchot, et al.
The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock.
Intensive Care Med., 42 (2016), pp. 370-378
asdasdasd
Article options
Tools